Page last updated: 2024-08-21

norfenfluramine and mdl 100907

norfenfluramine has been researched along with mdl 100907 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fink, GD; Li, MW; Ni, W; Thakali, K; Watts, SW1
Cadiz, EM; Kenney, J; Kwiatkowski, V; Robertson, KL; Rowland, NE1

Other Studies

2 other study(ies) available for norfenfluramine and mdl 100907

ArticleYear
The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 309, Issue:2

    Topics: Animals; Aorta; Blood Pressure; Ergolines; Fenfluramine; In Vitro Techniques; Ketanserin; Male; Norfenfluramine; Prazosin; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Adrenergic, alpha; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sympathectomy; Sympathetic Nervous System; Vasoconstriction

2004
Action of a serotonergic anorectic in meal-fed mice working for food.
    Behavioural pharmacology, 2012, Volume: 23, Issue:5-6

    Topics: Animals; Appetite Depressants; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Energy Intake; Feeding Behavior; Injections, Subcutaneous; Male; Meals; Mice; Mice, Inbred ICR; Nerve Tissue Proteins; Neurons; Norfenfluramine; Receptor, Serotonin, 5-HT2C; Reward; Satiety Response; Serotonin 5-HT2 Receptor Antagonists; Time Factors

2012